Paying for value from costly medical technologies: a framework for applying value-based payment reforms

2 June 2020 - Innovative medical products offer significant and potentially transformative impacts on health, but they create concerns about rising ...

Read more →

ICER finalises 2020 updates to methods and public meeting procedures for value assessment framework

31 January 2020 - Reflecting experience with previous framework, benchmarking with other HTA groups, and input from more than 100 organisations ...

Read more →

As value assessment frameworks evolve, are they finally ready for prime time?

9 September 2019 - Value assessment frameworks have emerged as tools to assist health care decision makers in the United States ...

Read more →

ICER Proposes Updates to 2020 Value Assessment Framework Methods and Procedures

21 August 2019 - Reflecting experience with current framework, benchmarking with other HTA groups, and public input, proposals include new emphasis ...

Read more →

ICER's value framework and patient feedback: Q&A with Steve Pearson

15 August 2019 - ICER invites all patient organizations and the general public to attend a webinar to learn more ...

Read more →

Novel approaches to value assessment within the cost-effectiveness framework

20 June 2019 - The second plenary session focused on the need to move beyond conventional cost-effectiveness analysis of healthcare interventions ...

Read more →

ICER seeks public input for 2020 value assessment framework

2 May 2019 - Accepting Open Input Through 10 June 2019. ...

Read more →

A health economics approach to US value frameworks: serving the needs of decision-making

22 February 2018 - Value assessment is an integral component of decision making in health and is the focus of a ...

Read more →

Patient-centered decision making: lessons from multi-criteria decision analysis for quantifying patient preferences

26 December 2018 - Patient preferences should be a central consideration in healthcare decision making.  ...

Read more →

Institute for Clinical and Economic Review announces final modified framework for assessing value of treatments for ultra rare diseases

13 November 2017 - Broader societal considerations and expanded cost-effectiveness ranges will be included for treatments targeting fewer than 10,000 patients. ...

Read more →

Should value frameworks take a ‘societal perspective’?

6 September 2017 - In 1996, the U.S. Panel on Cost-Effectiveness in Health and Medicine recommended that analysts conducting cost-effectiveness ...

Read more →

Can a new value framework help ease friction over orphan drug prices?

7 September 2017 - America’s healthcare debate has stalled in Congress, but constructive dialogue and innovation are thriving in specialised ...

Read more →

Dr Steve Pearson on using health technology assessment to guide decision making

23 July 2017 - Health technology assessment is a tool that helps to objectively evaluate evidence, which levels the playing field ...

Read more →

ICER seeks public comment on proposed value assessment framework for treatments that represent a potential major advance for serious ultra-rare conditions

25 July 2017 - ICER’s fundamental approach to value assessment remains constant with proposed changes for special circumstances. ...

Read more →

Institute for Clinical and Economic Review releases final value assessment framework for 2017-2019

22 June 2017 - Responds to public comment and sets key parameters for evidence review methods and process for stakeholder engagement. ...

Read more →